The Pentagon has awarded nearly $41 million to develop a ketamine-infused wafer designed to provide fast-acting pain relief to wounded soldiers without relying on injections or opioids. The product could eventually reach military personnel through an emergency regulatory pathway, but it still faces clinical, regulatory and manufacturing hurdles before it can be deployed. Ketamine has […]
<p>The post The Pentagon Is Spending $41 Million on Ketamine Wafers for Soldiers—But Why? first appeared on High Times.</p>
